SoftBank Vision Fund 2, a venture capital fund, led a $200m Series C round in Opentrons, a developer of pipetting robot technology, with participation from Khosla Ventures. “Biology opens the door to solve many of humanity’s grand challenges. For far too long, scientists and clinicians have been locked-in by slow, expensive, and overly complex lab solutions that underpin their work,” Jon Brennan-Badal, Opentrons CEO.